An FAQ-style article from an administrative buyer's perspective on understanding Hologic's quality control, their role in infection control, and what it means for a hospital's operational budget.
Continue ReadingA practical comparison of Hologic's diagnostic portfolio (Panther Fusion, Horizon DXA) against traditional alternatives. Written by a lab supervisor who learned the hard way.
Continue ReadingA procurement manager's perspective on why focusing on total cost of ownership (TCO) leads to better decisions for Hologic prone tables, mobility scooters, and rehabilitation equipment, with a look at biosensor technology.
Continue ReadingAn honest look at what it really costs when you choose medical equipment based on price alone, and how I learned to evaluate options like the Hologic Panther Plus through total cost of ownership.
Continue ReadingA purchasing administrator explains why the lowest price for hologic diagnostic solutions or icd devices is a trap. A practical guide to TCO for medical instruments.
Continue ReadingA step-by-step checklist for office administrators and procurement staff managing Hologic imaging, diagnostic, and surgical accessories documentation and shipping, based on real-world experience.
Continue ReadingA candid, experience-driven take on why trusting Hologic for breast imaging and molecular diagnostics doesn't mean buying everything they sell—and why that boundary made us better buyers.
Continue ReadingBased on real mistakes from a medical device buyer with over 7 years of experience – a practical checklist for ordering Hologic systems, surgical energy devices, incontinence products, and surgical gowns without hidden fees or specification errors.
Continue ReadingA quality control manager explains how strict specification reviews on Hologic systems—from mammography to endoscopes and electronic pipettes—directly impact patient safety, brand reputation, and operational costs.
Continue ReadingA quality inspector argues that hospitals must stop treating budget-friendly alternatives to Hologic equipment as 'close enough', explaining how overlooked specs in renewed mammography machines, handheld biopsy devices, and even seemingly unrelated tools like patient transfer devices can create cascading clinical and financial risks.
Continue Reading